IDEAYA Biosciences, Inc.
Company Stats
- Market Cap
- $3.7B
- as of Sep 30, 2026
- Shares Outstanding
- 96.5M
- Free Float
- 92.2%
Income Statement
- Revenue
- $218.7M
- Operating Income
- -$159.3M
- Net Income
- -$113.7M
- EBITDA
- -$156.6M
- Revenue Growth, 3Y
- 62.5%
- FCF Margin, 3Y Avg
- -1376.2%
- FCF Margin, Worst Year
- -3592.0%
Cash Flow
- Free Cash Flow
- -$73.5M
- FCF Yield
- -2.0%
- Owner FCF Yield
- -3.2%
Balance Sheet
- Cash & Equivalents
- $112.8M
Returns & Capital
- SBC, 3Y Avg
- $33.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $218.7M | -$73.5M | -33.6% |
| FY2024 | $7.0M | -$251.4M | -3592.0% |
| FY2023 | $23.4M | -$117.6M | -502.9% |
| FY2022 | $50.9M | -$90.6M | -177.9% |
| FY2021 | $27.9M | -$58.4M | -209.1% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 3, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back